[1] M.S. Lionakis, J.E. Edwards, Jr., Candida species in: J.E. Bennett, R. Doliin, M.J. Blaser (Eds.), Mandell, Duglas, and Bennett's Principles and Pracice of Infectious Diseases, Elsevier, Philadelphia, 2020, pp. 3087-3102.
[2] A. Singh, R. Verma, A. Murari, A. Agrawal, Oral candidiasis: An overview, J Oral Maxillofac Pathol 18(Suppl 1) (2014) S81-5.
[3] H. Masur, P.P. Rosen, D. Armstrong, Pulmonary disease caused by Candida species, Am J Med 63(6) (1977) 914-25.
[4] Z. Mohsenifar, S.K. Chopra, B.L. Johnson, D.H. Simmons, Candida pneumonia: experience with 20 patients, West J Med 131(3) (1979) 196-200.
[5] E. Haron, S. Vartivarian, E. Anaissie, R. Dekmezian, G.P. Bodey, Primary Candida pneumonia. Experience at a large cancer center and review of the literature, Medicine (Baltimore) 72(3) (1993) 137-42.
[6] D. Roux, S. Gaudry, D. Dreyfuss, J. El-Benna, N. de Prost, E. Denamur, G. Saumon, J.D. Ricard, Candida albicans impairs macrophage function and facilitates Pseudomonas aeruginosa pneumonia in rat, Crit Care Med 37(3) (2009) 1062-7.
[7] A.Y. Peleg, D.A. Hogan, E. Mylonakis, Medically important bacterial-fungal interactions, Nat Rev Microbiol 8(5) (2010) 340-9.
[8] D. Roux, S. Gaudry, L. Khoy-Ear, M. Aloulou, M. Phillips-Houlbracq, J. Bex, D. Skurnik, E. Denamur, R.C. Monteiro, D. Dreyfuss, J.D. Ricard, Airway fungal colonization compromises the immune system allowing bacterial pneumonia to prevail, Crit Care Med 41(9) (2013) e191-9.
[9] K.M. Pendleton, G.B. Huffnagle, R.P. Dickson, The significance of Candida in the human respiratory tract: our evolving understanding, Pathog Dis 75(3) (2017).
[10] D.M. Musher, S.S. Jesudasen, J.W. Barwatt, D.N. Cohen, B.J. Moss, M.C. Rodriguez-Barradas, Normal Respiratory Flora as a Cause of Community-Acquired Pneumonia, Open Forum Infect Dis 7(9) (2020) ofaa307.
[11] P.R. Murray, J.A. Washington, II, Microscopic and bacteriologic analysis of expectorated sputum, Mayo Clin Proc 50 (1975) 339-344.
[12] S.B. Thorsteinsson, D.M. Musher, T. Fagan, The diagnostic value of sputum culture in acute pneumonia, Jama 233(8) (1975) 894-5.
[13] D.M. Musher, K.R. Kubitschek, J. Crennan, R.E. Baughn, Pneumonia and acute febrile tracheobronchitis due to Haemophilus influenzae, Ann Intern Med 99(4) (1983) 444-50.
[14] G.W. Jordan, G.A. Wong, P.D. Hoeprich, Bacteriology of the lower respiratory tract as determined by fiber-optic bronchoscopy and transtracheal aspiration, J Infect Dis 134(5) (1976) 428-35.
[15] N.J. Gadsby, C.D. Russell, M.P. McHugh, H. Mark, A. Conway Morris, I.F. Laurenson, A.T. Hill, K.E. Templeton, Comprehensive molecular testing for respiratory pathogens in community-acquired pneumonia, Clin Infect Dis 62(7) (2016) 817-23.
[16] K. Yang, R.L. Kruse, W.V. Lin, D.M. Musher, Corynebacteria as a cause of pulmonary infection: a case series and literature review, Pneumonia (Nathan) 10 (2018) 10.
[17] G.L. Baum, The significance of Candida albicans in human sputum, N Engl J Med 263 (1960) 70-3.
[18] J. Rello, M.E. Esandi, E. Diaz, D. Mariscal, M. Gallego, J. Valles, The role of Candida sp isolated from bronchoscopic samples in nonneutropenic patients, Chest 114(1) (1998) 146-9.
[19] W. Meersseman, K. Lagrou, I. Spriet, J. Maertens, E. Verbeken, W.E. Peetermans, E. Van Wijngaerden, Significance of the isolation of Candida species from airway samples in critically ill patients: a prospective, autopsy study, Intensive Care Med 35(9) (2009) 1526-31.
[20] M. el-Ebiary, A. Torres, N. Fabregas, J.P. de la Bellacasa, J. Gonzalez, J. Ramirez, D. del Bano, C. Hernandez, M.T. Jimenez de Anta, Significance of the isolation of Candida species from respiratory samples in critically ill, non-neutropenic patients. An immediate postmortem histologic study, Am J Respir Crit Care Med 156(2 Pt 1) (1997) 583-90.
[21] R.J. Wallace, Jr., D.M. Musher, In honor of Dr. Sarah Branham, a star is born. The realization of Branhamella catarrhalis as a respiratory pathogen, Chest 90(3) (1986) 447-50.
[22] B. Allaouchiche, H. Jaumain, C. Dumontet, J. Motin, Early diagnosis of ventilator-associated pneumonia. Is it possible to define a cutoff value of infected cells in BAL fluid?, Chest 110(6) (1996) 1558-65.
[23] A. Torres, M. El-Ebiary, N. Fabregas, J. Gonzalez, J.P. de la Bellacasa, C. Hernandez, J. Ramirez, R. Rodriguez-Roisin, Value of intracellular bacteria detection in the diagnosis of ventilator associated pneumonia, Thorax 51(4) (1996) 378-84.
[24] K.J. Brasel, B. Allen, C. Edmiston, J.A. Weigelt, Correlation of intracellular organisms with quantitative endotracheal aspirate, J Trauma 54(1) (2003) 141-4; discussion 144-6.
[25] A.N. Neely, E.J. Law, I.A. Holder, Increased susceptibility to lethal Candida infections in burned mice preinfected with Pseudomonas aeruginosa or pretreated with proteolytic enzymes, Infect Immun 52(1) (1986) 200-4.
[26] E. Azoulay, J.F. Timsit, M. Tafflet, A. de Lassence, M. Darmon, J.R. Zahar, C. Adrie, M. Garrouste-Orgeas, Y. Cohen, B. Mourvillier, B. Schlemmer, G. Outcomerea Study, Candida colonization of the respiratory tract and subsequent pseudomonas ventilator-associated pneumonia, Chest 129(1) (2006) 110-7.